An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Cardiac experts share the true impact of replacing a sugary snack with blueberries.

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

Medically reviewed by Suzanne Fisher, RD Key Takeaways A study shows that eating an avocado daily for six months improved ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...

One of the most common questions I hear from patients is, "My cholesterol was flagged as abnormal, but you told me everything looked good. How can that be?" Recently, a patient named Rose asked ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

Eli Lilly is laying the groundwork for a phase 2 trial of the lipid-lowering gene editor it acquired from Verve Therapeutics, with the candidate now showing strong and consistent cholesterol ...

Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.

The Conversation reports C-reactive protein is a superior heart disease risk marker over cholesterol, urging universal screening for better prevention.